Xenon Pharmaceuticals Inc. - stock earnings
XENE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -44.7 million USD | 5.4 million USD |
| 2023Q3 | -48.5 million USD | ? USD |
| 2023Q2 | -47.5 million USD | ? USD |
| 2023Q1 | -41.7 million USD | ? USD |
| 2022Q4 | -37.4 million USD | 8766 USD |
| 2022Q3 | -37.2 million USD | 132000 USD |
| 2022Q2 | -31.2 million USD | 536000 USD |
| 2022Q1 | -19.7 million USD | 8.8 million USD |
| 2021Q4 | -25.6 million USD | 3.7 million USD |
| 2021Q3 | -15.4 million USD | 8.1 million USD |
| 2021Q2 | -22.1 million USD | 2.2 million USD |
| 2021Q1 | -15.8 million USD | 4.4 million USD |
| 2020Q4 | -12.3 million USD | 5.2 million USD |
| 2020Q3 | -8.9 million USD | 6.6 million USD |
| 2020Q2 | -175000 USD | 13.4 million USD |
| 2020Q1 | -7.5 million USD | 7.1 million USD |
| 2019Q4 | -11.4 million USD | 3.3 million USD |
| 2019Q3 | -8.9 million USD | 3.5 million USD |
| 2019Q2 | -10.0 million USD | ? USD |
| 2019Q1 | -11.3 million USD | ? USD |
| 2018Q4 | -8.6 million USD | 6.0 million USD |
| 2018Q3 | -14.4 million USD | ? USD |
| 2018Q2 | -7.8 million USD | ? USD |
| 2018Q1 | -3.8 million USD | 16000 USD |
| 2017Q4 | -8.1 million USD | 16000 USD |
| 2017Q3 | -7.7 million USD | 264000 USD |
| 2017Q2 | -7.4 million USD | 15000 USD |
| 2017Q1 | -7.5 million USD | 16000 USD |
| 2016Q4 | -6.0 million USD | 376000 USD |
| 2016Q3 | -7.7 million USD | 413000 USD |
| 2016Q2 | -6.0 million USD | 413000 USD |
| 2016Q1 | -3.3 million USD | 601000 USD |
| 2015Q4 | -3.9 million USD | 3.2 million USD |
| 2015Q3 | -3.8 million USD | 4.3 million USD |
| 2015Q2 | 1.2 million USD | 4.0 million USD |
| 2015Q1 | -4.2 million USD | 4.0 million USD |
| 2014Q4 | 1.2 million USD | 4.9 million USD |
| 2014Q3 | 9.2 million USD | 13.2 million USD |
| 2014Q2 | 1.2 million USD | 5.3 million USD |
| 2014Q1 | 1.4 million USD | 5.0 million USD |
| 2013Q4 | 2.5 million USD | 5.6 million USD |
| 2013Q3 | 6.4 million USD | 10.8 million USD |
| 2013Q2 | 3.1 million USD | 11.0 million USD |
| 2012Q4 | ? USD | 14.3 million USD |
XENE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -182.4 million USD | ? USD |
| 2022 | -125.4 million USD | 9.4 million USD |
| 2021 | -78.9 million USD | 18.4 million USD |
| 2020 | -28.8 million USD | 32.2 million USD |
| 2019 | -41.6 million USD | 6.8 million USD |
| 2018 | -34.5 million USD | ? USD |
| 2017 | -30.7 million USD | 311000 USD |
| 2016 | -23.0 million USD | 1.8 million USD |
| 2015 | -15.8 million USD | 15.6 million USD |
| 2014 | 13.0 million USD | 28.4 million USD |
| 2013 | 12.0 million USD | 27.4 million USD |
| 2012 | -4.3 million USD | 14.3 million USD |
| 2011 | -12.0 million USD | 6.9 million USD |
XENE
Price: $40.65
52 week price:
Earnings Per Share: -2.73 USD
P/E Ratio: -18.81
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 730900
Ebitda: -8.5 millionMarket Capitalization: 3.2 billion